Cancer Immunotherapy Industry Statistics

You might be interested in: Cancer, Oncology, Vaccine, Drug, Pharmaceutical, Cell Therapy, Immunotherapy, Stem Cell, Cytokine, Gene Therapy, Herceptin, Biotherapy, Electroporation, Therapeutic Antibody.

1-7 of about 300 reports for Cancer Immunotherapy

Pathology Description in the US Forecast

  • March 2015
    19 pages
  • Cancer  

    Ovarian Cancer  

    Oncology  

  • United States  

    Taiwan  

View report >

Pathology Description in the US

  • January 2015
    76 pages
  • Cancer  

    Biopharmaceutic  

    Clinical Trial  

  • United States  

View report >

Pathology Description in the US

  • January 2015
    32 pages
  • Cancer  

    Oncology  

    Breast Cancer  

  • United States  

View report >

Biotechnology Statistics

  • March 2015
    26 pages
  • Biotechnology  

    Biotech  

    Oncology  

View report >

Pathology Description in the US

  • January 2015
    32 pages
  • Cancer  

  • United States  

View report >

Biological Therapy Industry in the US Forecast

  • January 2014
    22 pages
  • Cancer  

    Vaccine  

    Therapy  

  • United States  

View report >

Immunotherapy Industry in the US

  • January 2014
    12 pages
  • Immunotherapy  

    Cancer Immunoth  

    Cancer  

  • United States  

View report >
6 reports for Cancer Immunotherapy

Purchase Reports From Reputable Market Research Publishers
(From $ 1 874 - $ 6 813)

Competitor Analysis: Therapeutic Antibodies 2015 - Biosimilars & Biosuperiors

Competitor Analysis Therapeutic Antibodies 2015 Biosimilars Biosuperiors

  • $ 1 716
  • Industry report
  • April 2015
  • by La Merie Publishing

Competitor Analysis Therapeutic Antibodies 2015 Biosimilars Biosuperiors This Competitive Intelligence Report about Therapeutic Antibodies 2015 Biosimilars Biosuperiors provides a competito


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.